5 Einträge gefunden

1. Outcome and fewer indications for adjuvant therapy for patients with oral squamous cell carcinomas under standardized tumor board conditions

   1. Gröbe, Alexander
   2. Rybak, Lena
   3. Schön, Gerhard
   4. Smeets, Ralf
   5. Tribius, Silke
   6. Schafhausen, Philippe
   7. Clauditz, Till S

   2016 - Forschungsinformationssystem des UKE
2. Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib

   1. Cortes, Jorge E
   2. Khoury, Hanna J
   3. Kantarjian, Hagop M
   4. Lipton, Jeff H
   5. Kim, Dong-Wook
   6. Schafhausen, Philippe
   7. Matczak, Ewa

   2016 - Forschungsinformationssystem des UKE
3. Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib

   1. Brümmendorf, Tim H
   2. Cortes, Jorge E
   3. Khoury, Hanna J
   4. Kantarjian, Hagop M
   5. Kim, Dong-Wook
   6. Schafhausen, Philippe
   7. Conlan, Maureen G

   2016 - Forschungsinformationssystem des UKE
4. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature

   1. Zielinski, Valerie
   2. Laban, Simon
   3. Tribius, Silke
   4. Schafhausen, Philippe
   5. Veldhoen, Simon
   6. Knecht, Rainald
   7. Clauditz, Till

   2016 - Forschungsinformationssystem des UKE
5. Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

   1. Al-Ali, Haifa Kathrin
   2. Griesshammer, Martin
   3. le Coutre, Philipp
   4. Waller, Cornelius F
   5. Liberati, Anna Marina
   6. Schafhausen, Philippe
   7. Tavares, Renato

   2016 - Forschungsinformationssystem des UKE - frei zugänglich